Push for Western Australia’s First Childhood Cancer Survivorship Clinic

The clinical triumph of childhood cancer survival is increasingly overshadowed by a secondary crisis: the long-term morbidity associated with the very treatments that save lives. As survival rates improve, the medical community is now facing the systemic failure to provide longitudinal, specialized care for those transitioning from pediatric patients to adult survivors.

Key Clinical Takeaways:

• A critical gap exists between pediatric and adult cancer treatments, with childhood options lagging in innovation and often relying on toxic therapies.
• Survivors face devastating life-long side effects and an increased risk of deadly secondary cancers due to the impact of radiotherapy and chemotherapy on developing bodies and brains.
• There is an urgent push for Western Australia’s first dedicated statewide childhood cancer survivorship clinic to manage the complex health needs of adult survivors.

Pediatric oncology operates under a different biological paradigm than adult oncology. Cancers in children develop differently, spread more aggressively and often strike at random, necessitating a distinct approach to pathogenesis and treatment. Despite these differences, the gap in available life-saving treatments for children remains unacceptable. Current protocols, although often curative, are frequently characterized by extreme toxicity. These interventions do not merely target malignant cells; they impact the developing physiological systems of the child, leading to permanent neurological and systemic damage.

The Toxicity of the Standard of Care

The reliance on traditional radiotherapies and chemotherapies presents a profound clinical trade-off. While these modalities are essential for eliminating primary tumors, their application in developing bodies often results in devastating life-long side effects. The toxicity extends beyond the immediate site of treatment, affecting the developing brain and endocrine systems, which can lead to cognitive impairments and chronic organ dysfunction in adulthood.

More alarming is the statistical probability of secondary malignancies. The same agents used to treat the initial childhood cancer can induce genetic mutations that lead to deadly secondary cancers later in life. This creates a lifelong state of medical vulnerability for the survivor, transforming a “cure” into a permanent requirement for high-intensity medical surveillance. For families navigating these risks, it is imperative to engage with board-certified pediatric oncology specialists who can balance aggressive treatment with long-term toxicity mitigation.

“Cancers in children are very different to cancers in adults – they develop differently, spread more rapidly and aggressively, and in most cases, they appear to strike at random.”

Addressing the Infrastructure Gap in Western Australia

The current healthcare infrastructure in Western Australia is optimized for the acute phase of diagnosis and treatment, but it falters during the survivorship phase. Perth Children’s Hospital specializes in the coordination of care for children diagnosed with cancer and facilitates critical participation in national and international clinical trials through groups like the Children’s Oncology Group and St Jude Children’s Research Hospital. However, once a patient ages out of pediatric care, they often fall into a clinical void.

Pressure is mounting on the WA Government to establish a dedicated statewide clinic specifically for adults who have survived childhood cancer. The necessity for such a facility stems from the fact that adult general practitioners and oncologists may not be equipped to manage the specific, delayed-onset toxicities associated with pediatric protocols. This represents not merely a matter of convenience but a clinical necessity to reduce morbidity and identify secondary cancers at an early, treatable stage. To manage these complex transitions, survivors often require the expertise of specialized survivorship clinics capable of multidisciplinary longitudinal care.

The Role of Innovation and Research

The WA Kids Cancer Centre, led by the Kids Research Institute Australia, is actively working to eliminate the treatment gap. By pursuing innovative research and ambitious new treatment ideas, the centre aims to move beyond the toxic standard of care. With close to 1,000 children and adolescents diagnosed annually in Australia—and the tragic reality that three children a week do not survive—the drive for non-toxic, targeted therapies is a public health priority.

The goal is to shift the trajectory from mere survival to “healthy survival,” where the cure does not come at the cost of the patient’s future quality of life. This evolution in care requires a synergy between cutting-edge research and a robust clinical pipeline that supports the patient from the first diagnosis through their entire adult life.

Psychosocial Morbidity and Family Support

The impact of a cancer diagnosis extends beyond the biological. The sudden and overwhelming nature of the diagnosis creates shockwaves throughout the family unit, manifesting as anxiety, disbelief, anger, guilt, and sadness. Because children’s reactions differ fundamentally from those of adults, specialized psychological intervention is required.

The expansion of Children’s Counselling services in 2025, supported by the Channel 7 Telethon Trust, represents a critical step in addressing the behavioral, social, and emotional difficulties caused by cancer. These free, short-term services provide a safe environment for children to process their trauma. For families struggling with the emotional burden of a diagnosis, accessing vetted pediatric counseling services is essential for the long-term mental health of both the patient and their caregivers.

The trajectory of pediatric oncology is moving toward a more holistic model. While the immediate focus remains on survival, the push for a dedicated survivorship clinic in Western Australia acknowledges that the medical journey does not end with the final chemotherapy session. The future of the field lies in the integration of innovative, less-toxic treatments and a lifelong continuum of care that protects the survivor from the long-term consequences of their cure.

Ensuring that survivors receive the precise level of monitoring and rehabilitative care required is a complex task. Whether seeking advanced research trials or long-term survivorship management, patients and families should utilize professional directories to find specialists who are current with the latest pediatric and adult oncology guidelines.

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.